VR Adviser, LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$2.0B
Holdings
27
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (27 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | APGEAPOGEE THERAPEUTICS INC | 8,493,321 | $641.1M | 31.67% | |
| 2 | ORKAORUKA THERAPEUTICS INC | 4,148,428 | $125.7M | 6.21% | |
| 3 | VRDNVIRIDIAN THERAPEUTICS INC | 3,882,709 | $120.8M | 5.97% | |
| 4 | SYRESPYRE THERAPEUTICS INC | 3,685,448 | $120.7M | 5.96% | |
| 5 | KALVKALVISTA PHARMACEUTICALS INC | 6,728,985 | $108.7M | 5.37% | |
| 6 | OCULOCULAR THERAPEUTIX INC | 7,315,547 | $88.8M | 4.39% | |
| 7 | YB4PSAVARA INC | 13,740,375 | $82.9M | 4.09% | |
| 8 | COGTCOGENT BIOSCIENCES INC | 2,000,000 | $71.0M | 3.51% | |
| 9 | ERASERASCA INC | 17,857,083 | $66.4M | 3.28% | |
| 10 | CTMXCYTOMX THERAPEUTICS INC | 15,561,500 | $66.3M | 3.27% | |
| 11 | MAZEMAZE THERAPEUTICS INC | 1,548,569 | $64.2M | 3.17% | |
| 12 | JBIOJADE BIOSCIENCES INC | 3,220,364 | $49.7M | 2.45% | |
| 13 | ELVNENLIVEN THERAPEUTICS INC | 3,226,331 | $49.7M | 2.45% | |
| 14 | ORICORIC PHARMACEUTICALS INC | 5,676,230 | $46.4M | 2.29% | |
| 15 | ENGNENGENE HOLDINGS INC | 4,771,414 | $43.1M | 2.13% | |
| 16 | DYNDYNE THERAPEUTICS INC | 2,173,913 | $42.5M | 2.10% | |
| 17 | DNTHDIANTHUS THERAPEUTICS INC | 1,000,000 | $41.2M | 2.04% | |
| 18 | UPBUPSTREAM BIO INC | 1,169,298 | $31.7M | 1.57% | |
| 19 | HELPCYBIN INC | 3,840,250 | $31.4M | 1.55% | |
| 20 | ZURAZURA BIO LTD | 5,345,115 | $28.0M | 1.38% | |
| 21 | VORVOR BIOPHARMA INC | 1,943,766 | $25.4M | 1.26% | |
| 22 | CBIOCRESCENT BIOPHARMA INC. | 2,133,576 | $25.3M | 1.25% | |
| 23 | SEPNSEPTERNA INC | 610,808 | $17.0M | 0.84% | |
| 24 | SRZNSURROZEN INC | 632,931 | $14.3M | 0.71% | |
| 25 | CGEMCULLINAN THERAPEUTICS INC | 1,379,965 | $14.3M | 0.71% | |
| 26 | ARTVARTIVA BIOTHERAPEUTICS INC | 1,609,569 | $6.9M | 0.34% | |
| 27 | —CASI PHARMACEUTICALS INC | 987,259 | $839K | 0.04% |